OraSure Technologies   Report issue

For profit Phase 1
Founded: Bethlehem PA United States (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

Key: OraSure Technologies (0) Acquired (2)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

vax-id (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 2